(Q33806643)

English

Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo

scientific article

Statements

Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo (English)
5957-5967

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit